Advertisement

 

 

Desethylamiodarone-A metabolite of amiodarone-Induces apoptosis on T24 human bladder cancer cells via multiple pathways.

Desethylamiodarone-A metabolite of amiodarone-Induces apoptosis on T24 human bladder cancer cells via multiple pathways.
Author Information (click to view)

Bognar Z, Fekete K, Antus C, Hocsak E, Bognar R, Tapodi A, Boronkai A, Farkas N, Gallyas F, Sumegi B, Szanto A,


Bognar Z, Fekete K, Antus C, Hocsak E, Bognar R, Tapodi A, Boronkai A, Farkas N, Gallyas F, Sumegi B, Szanto A, (click to view)

Bognar Z, Fekete K, Antus C, Hocsak E, Bognar R, Tapodi A, Boronkai A, Farkas N, Gallyas F, Sumegi B, Szanto A,

Advertisement
Share on FacebookTweet about this on TwitterShare on LinkedIn

PloS one 2017 12 0812(12) e0189470 doi 10.1371/journal.pone.0189470
Abstract

Bladder cancer (BC) is a common malignancy of the urinary tract that has a higher frequency in men than in women. Cytostatic resistance and metastasis formation are significant risk factors in BC therapy; therefore, there is great interest in overcoming drug resistance and in initiating research for novel chemotherapeutic approaches. Here, we suggest that desethylamiodarone (DEA)-a metabolite of amiodarone-may have cytostatic potential. DEA activates the collapse of mitochondrial membrane potential (detected by JC-1 fluorescence), and induces cell death in T24 human transitional-cell bladder carcinoma cell line at physiologically achievable concentrations. DEA induces cell cycle arrest in the G0/G1 phase, which may contribute to the inhibition of cell proliferation, and shifts the Bax/Bcl-2 ratio to initiate apoptosis, induce AIF nuclear translocation, and activate PARP-1 cleavage and caspase-3 activation. The major cytoprotective kinases-ERK and Akt-are inhibited by DEA, which may contribute to its cell death-inducing effects. DEA also inhibits the expression of B-cell-specific Moloney murine leukemia virus integration site 1 (BMI1) and reduces colony formation of T24 bladder carcinoma cells, indicating its possible inhibitory effect on metastatic potential. These data show that DEA is a novel anti-cancer candidate of multiple cell death-inducing effects and metastatic potential. Our findings recommend further evaluation of its effects in clinical studies.

Submit a Comment

Your email address will not be published. Required fields are marked *

10 − three =

[ HIDE/SHOW ]